Florian Holsboer
Max Planck Institute of Psychiatry
Kraepelinstr. 2-10
80804 Munich
Germany
Name/email consistency: high
- Stress hormone regulation: biological role and translation into therapy. Holsboer, F., Ising, M. Annu. Rev. Psychol (2010)
- CRH signaling. Molecular specificity for drug targeting in the CNS. Refojo, D., Holsboer, F. Ann. N. Y. Acad. Sci. (2009)
- Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists. Holsboer, F., Ising, M. Eur. J. Pharmacol. (2008)
- How can we realize the promise of personalized antidepressant medicines?. Holsboer, F. Nat. Rev. Neurosci. (2008)
- The future of antidepressant pharmacogenetics is arriving. Introduction. Holsboer, F. Prog. Neuropsychopharmacol. Biol. Psychiatry (2005)
- Unipolar versus bipolar disorder: a distinction not helpful for studies of causality. Holsboer, F. Curr. Psychiatry. Rep (2005)
- Corticotropin-releasing hormone modulators and depression. Holsboer, F. Curr. Opin. Investig. Drugs (2003)
- The role of peptides in treatment of psychiatric disorders. Holsboer, F. J. Neural Transm. Suppl. (2003)
- High-quality antidepressant discovery by understanding stress hormone physiology. Holsboer, F. Ann. N. Y. Acad. Sci. (2003)
- Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. Holsboer, F. J. Affect. Disord (2001)
- Prospects for antidepressant drug discovery. Holsboer, F. Biol. Psychol (2001)
- Antidepressant drug discovery in the postgenomic era. Holsboer, F. World J. Biol. Psychiatry (2001)
- The stress hormone system is back on the map. Holsboer, F. Curr. Psychiatry. Rep (2000)
- The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. Holsboer, F. J. Psychiatr. Res (1999)
